Citigroup’s Autonomix Medical AMIX Stock Holding History

Citigroup’s Portfolio AMIX Stock Details AMIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1	Closed	-$29	–	6540
2025 Q3	$29	Buy	+1	New	+$26	﹤0.01%	5881

Other funds holding AMIX

Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

IRC

Investors Research Corp Atlanta, Georgia $559M AUM 21.55% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citigroup's AMIX Position: Q4 2025 in Review

Citigroup sold out of Autonomix Medical (AMIX) in Q4 2025, closing a stake of 1 share — an estimated $29 sold.

Citigroup first reported a position in AMIX in Q3 2025 and held it in 1 quarter. The position peaked at $29 in Q3 2025. 11 funds tracked by Wall St. Rank hold AMIX as of Q4 2025.

Citigroup reported no remaining Autonomix Medical position as of Q4 2025 after selling out during the quarter.
Citigroup sold 1 Autonomix Medical share in Q4 2025, an estimated $29.
Citigroup first reported a position in Autonomix Medical in Q3 2025 and held it in 1 quarter.
Citigroup's Autonomix Medical position peaked at $29 in Q3 2025.
11 funds tracked by Wall St. Rank held Autonomix Medical as of Q4 2025.

Based on Citigroup's 13F filing for Q4 2025, filed 13 Feb 2026.